Introduction

Hospital readmissions happen when a patient must return to the medical facility within 4

weeks of being released due to problems from their prior condition. Within 4 weeks of release,

about 1 in 4 heart failure (HF) clients are readmitted, and around 50% are transferred back within

6 months (Khan et al., 2021). This paper evaluates the reasons for readmissions for HF patients

and outlines interventions to improve the issue.

HF is the main factor in readmissions to the hospital and hospitalization, as well as a

substantial contributor to death, illness, and reduced quality of life. Following a release,

impediments to readmission and recurrence include HF brought on by several co-morbidities,

pharmacological non - compliance or poor adherence, as well as economic considerations (Al-

Tamimi et al., 2021). Insufficient adherence to recommended drugs is a significant issue among

HF clients. Higher HF relapses due to decreased functional ability, and potentially mortality

cause readmissions. Numerous comorbidities, such as those seen by COVID-19 patients, can

also be a barrier that causes readmissions for patients with (HF).